MaxiVAX und Minaris Regenerative Medicine treffen Herstellungsvereinbarung für die Krebsimmuntherapie MVX-ONCO-2
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://www.b3cnewswire.com/images/client_pictures/Minaris/PR24/2021022_-MaxiVax_und_Minaris_Regenerative_Medicine_treffen_Herstellungsvereinbarung.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts: